Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MEDIROM Healthcare Technologies ( (MRM) ) has issued an update.
On December 12, 2025, MEDIROM Healthcare Technologies Inc. completed the sale and issuance of JPY400,000,000 in convertible corporate bonds to 11 investors. The proceeds will be used for general corporate and financing purposes. The bonds were issued outside the United States under Regulation S, and are not registered under the Securities Act, limiting their offer and sale within the U.S. This strategic move is expected to support the company’s financial flexibility and operational growth.
The most recent analyst rating on (MRM) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on MEDIROM Healthcare Technologies stock, see the MRM Stock Forecast page.
Spark’s Take on MRM Stock
According to Spark, TipRanks’ AI Analyst, MRM is a Neutral.
The overall stock score is primarily influenced by financial performance and technical analysis. While the company shows strong revenue growth, profitability and liquidity challenges are significant concerns. The technical indicators suggest a bearish trend, but the stock appears undervalued based on its P/E ratio.
To see Spark’s full report on MRM stock, click here.
More about MEDIROM Healthcare Technologies
MEDIROM Healthcare Technologies Inc. operates in the healthcare industry, focusing on providing healthcare services and technologies. The company is based in Tokyo, Japan, and is involved in offering innovative solutions to enhance health and wellness.
Average Trading Volume: 2,421,747
Technical Sentiment Signal: Hold
Current Market Cap: $17.23M
For a thorough assessment of MRM stock, go to TipRanks’ Stock Analysis page.